Skip to main content
Premium Trial:

Request an Annual Quote

Geneus 4.0, MDS42recA Competent Cells

Premium
GenoLogics has released Geneus 4.0, a new version of its lab and data management system for genomics research. According to the company, Geneus 4.0 can manage sequencing data from Illumina, ABI, Roche, and other vendors. Also, as a member of Illumina’s Connect bioinformatics partnership program, the company is now able to integrate sequencing-based workflows from Illumina’s Genome Analyzer into its system. Geneus is part of GenoLogics’ Solutions for Research Informatics, which enable data from different science workflows and across multiple labs to be tracked, captured, and stored in a single lab and data management system.
 

 
Scarab Genomics has launched MDS42recA competent E. coli cells. The company has improved its Multiple Deletion Strain 42 competent cell line by removing the recA gene from the E. coli genome. As a result, the overall stability of the MDS42 genome and of introduced plasmids is increased, and transformation efficiencies and protein expression are improved, according to Scarab.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.